|
14U035,25萬IU/Vial更動後
中文名:血栓溶素注射劑
廠牌:綠十字
14U035,25萬IU/Vial更動前
中文名:
廠牌:
|
| Product
name |
|
| Dosage
form |
|
| Indications |
|
| Administration
& Dosage |
IV,
Pulmonary embolism: IV, initial 4400 IU/kg> 10 min, followed by 4400 IU/kg/hr for 12 hrs. |
|
| Contraindication |
hypersensitivity to urokinase;
active internal bleeding;
severe uncontrolled hypertension;
recent intracranial or intraspinal surgery or trauma;
intracranial neoplasm, arteriovenous malformation, or aneurysm;
known bleeding diathesis; history of cerebrovascular accident |
|
| Precaution |
|
| Adverse
reaction |
| Decreased hematocrit; anaphylaxis; infusion reaction; reperfusion ventricular; arrhythmias; vascular embolization; significant bleeding |
|
| Drug
Interaction |
|
| Pregnancy
Category |
|
| Notes |
| Heparin should be discontinued during the IV administration of urokinase |
|
